drugset / Trial / NCT04474626

Isoquercetin in Sickle Cell Anemia

NCT04474626

NaSingle-groupOpen-labelTreatment

Summary

This research study is being done to assess the safety and effectiveness of isoquercetin to reduce levels of soluble P-Selectin in patients with sickle cell disease. Isoquercetin is a naturally occurring flavonoid-or vitamin. You will find quercetin and isoquercetin in fruits and vegetables. The names of the study drug involved in this study are/is: \- Isoquercetin

Timeline

Start
2020-12
Primary completion
2022-12-31
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Isoquercetin Small molecule Oral